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The antinociceptive activity of the crude extract and fractions of
Stryphnodendron adstringens (Martius) Coville (barbatimão) was
evaluated. Three experimental models of pain induction were used:
abdominal writhing, formalin, and hot plate. The results
demonstrated an antinociceptive effect of barbatimão in the
experimental models of writhing induced by acetic acid and pain
induced by formalin. However, the extracts did not significantly
alter latency time on the hot plate in mice. These results suggest
that barbatimão extract has a peripheral antinociceptive effect.
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Medicinal plants play an important role in folk
medicine, and different plant species have been used in the
treatment of many diseases. Detailed studies are necessary
to prove their biological activity and provide necessary
information about their therapeutic use.
Popularly known as barbatimão, Stryphnodendron
adstringens (Mart.), Coville, Leguminosae, is a medicinal
plant abundant in central Brazil and has long been used as
a popular herbal medicine. Pharmacological studies with
this plant have demonstrated that it possesses anti-
inflammatory properties (Bersani-Amado et al., 1996;
Lima et al., 1998) and protects gastric mucous membranes
(Audi et al., 1999). There also are reports that barbatimão
extracts have cicatrizing (Lopes et al., 2005; Neves et al.,
1992; Panizza et al., 1988), antioxidant (Lopes et al.,
2005; Sanches et al., 2005), antiviral (Felipe et al., 2006),
antiprotozoa (Holetz et al., 2005), and antimicrobial effects
(Audi et al., 1999; Ishida et al., 2006; Sanches et al.,
2005).
The purpose of the present study was to evaluate the
possible antinociceptive activity of the crude extract and
fractions of barbatimão in several animals models of
nociception.
MATERIAL AND METHODS
Plant material and extract preparation
The stem bark of Stryphnodendron adstringens
(Martius) Coville, Leguminosae, was collected in São
Jerônimo da Serra (longitude: 23º 43' 7.8" S; latitude: 50º
45' 23.5" W; altitude: 926 m) in the state of Paraná, Brazil,
in October 1995. A voucher specimen was deposited at the
Herbarium of the Biology Department under number
HUM-3800. Air dried stem bark (1500 g) was extracted in
Ultra-Turax® with Acetone:H2O (7:3; v/v). The organic
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solvent was eliminated by reduced pressure and lyophilised
to yield a barbatimão crude extract (633 g). The
lyophilized barbatimão crude extract (500 g) was
resuspended in H2O and then fractionated with ethyl acetate
to yield H2O (F1; 386 g) and ethyl-acetate (F2; 98 g)
fractions. Both F1 and F2 were concentrated under reduced
pressure to eliminate the organic solvent, lyophilized, and
stored at -20 ºC. The barbatimão crude extract and
fractions F1 and F2 were resuspended in distilled water at
the desired concentrations before use.
Animals
Adult male Wistar rats weighing 200-220 g and male
Swiss mice weighing 25-35 g were used. They were housed
five per cage and maintained in a room with controlled
temperature (22 ± 2 ºC) under a 12 h dark-light cycle with
free access to standard chow and tap water throughout the
experimental period. The protocol for these experiments
was approved by the Animal Ethics Committee of
University of Maringá under approval number 047/CEEA.
Writhing test
The response to intraperitoneal injection of 0.6%
acetic acid (i.e., contraction of the abdominal muscles and
elongation of the hind limbs) was induced by the method of
Koster et al. (1959). Male Swiss mice (25–35 g, n = 8)
were treated orally with the crude extract and fractions
(200, 400, and 800 mg/kg body weight), indomethacin®
(Sigma, 5 mg/kg body weight), the reference nonsteroidal
anti-inflammatory drug, or saline (control group) 30 min
before injection of 0.6% acetic acid (0.1 ml/10 g body
weight). The mice were placed in transparent glass
cylinders, and the number of abdominal writhes produced
in these animals was counted over a period of 20 min. The
antinociceptive activity was evaluated in terms of number
of writhes.
Formalin test
The formalin test was performed according to the
method described previously by Correa and Calixto (1993).
The mice were treated orally with the crude extract and
fractions (800 mg/kg body weight) or indomethacin
(5 mg/kg body weight) 30 min before intraplantar injection
of 1% formalin (0.5 ml) into the left hind paw of the animal.
The animals were placed in a mirrored cylinder. The
reaction to pain then was observed, and the time the animal
spent licking or biting its paw was measured with a
chronometer during the first phase (0–5 min, neurogenic
pain) and during the second phase (15–35 min, tonic pain).
Hot-plate test
The latency time in the hot-plate test was measured
by the method of Eddy and Leimback (1953). The animals
were divided into groups of eight animals each. The
temperature of the plate (Ugo Basile, Varese, Italy) was
fixed at 55.0 ± 0.5 °C. The latency time to exhibit a reaction
(i.e., jumps, licking one of the hind limbs, or one of the
forelimbs, tapping) was measured 30 and 60 min after
administration of the crude extract and fractions (800 mg/kg
body weight, p.o.), meperidine® (Cristália, 50 mg/kg body
weight, i.p.), the reference opioid analgesic drug, or saline
(control group). Basal latencies were recorded before
treatment. The cutoff time was 30 s to avoid tissue damage.
Statistical analysis
The results are presented as mean ± standard error of
the mean (S.E.M.). The data were subjected to analysis of
variance (ANOVA) followed by Tukey’s post hoc test.
P < 0.05 was considered as the significance level.
RESULTS
The barbatimão crude extract and both fractions, F1
(aqueous fraction) and F2 (ethyl-acetate fraction), dose-
dependently reduced acetic acid-induced writhing when
administered orally (400 and 800 mg/kg body weight).
Only the F1 fraction inhibited writhing at a dose of 200 mg/kg
body weight. All of the extracts at the 800 mg/kg dose
inhibited writhing similarly to indomethacin (5 mg/kg).
In the formalin test, the barbatimão crude extract and
F1 fraction (800 mg/kg) caused marked inhibition only in
the late phase. The F2 fraction was not effective in both
phases of this model.
The barbatimão crude extract (800 mg/kg) and the
F1 fraction (800 mg/kg) pretreatment increased response
latency in the hot plate test. This effect, however, was very
minimal compared to the effect of meperidine, the analgesic
reference drug. Treatment with the F2 fraction did not alter
the response time of the animals. Data are presented in
Table I.
DISCUSSION
The results obtained in the present study
demonstrated that the barbatimão crude extract and
fractions exhibited antinociceptive activity in the models
tested. This effect was more significant against chemically
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(acetic acid and formalin tests) than thermally (hot plate)
induced nociception.
Acetic acid causes inflammatory pain by inducing
capillary permeability (Amico-Roxas et al., 1984) and
liberating endogenous substances that excite pain nerve
endings (Raj, 1996). Traditional anti-inflammatory drugs
(e.g., nonsteroidal anti-inflammatory drugs) inhibit COX
in peripheral tissues, thus interfering with production of
mediators that stimulate primary afferent nociceptors
(Fields, 1987). The formalin test, characterized by two
phases, is used to evaluate the mechanism by which an
animal responds to moderate, continuous pain generated by
the injured tissue (Abbott et al., 1995). The early phase
(immediately after formalin injection) seems to be caused
by C-fiber activation induced by the peripheral stimulus.
The late phase (starting approximately 20 min after
injection) appears to depend on the combination of an
inflammatory reaction, activation of N-methyl-D-aspartate
(NMDA) and non-NMDA receptors, and the nitric oxide
cascade (Davidson and Carlton, 1998) in the peripheral
tissue and functional changes in the dorsal horn of the
spinal cord (Abbott et al., 1995).
The extract showed remarkable activity in the writhing
test induced by acetic acid and in the late phase of the
formalin test, both related to a peripheral inflammatory pain
(Ahmadiani et al., 1998; Collier et al., 1968). In contrast, the
effects of the extract in the hot plate test, used to evaluate
specific central antinociception (Parkhouse et al., 1979),
were minimal. Although some doses showed a significant
difference compared to the control group, the antinociceptive
effect of meperidine (reference drug) was much more evident.
In addition, the effect of crude extract and fractions in the
early phase of the formalin test was not different from
control. The nociception of this phase may be a direct result
of stimulation of nociceptive neurons (Coderre, Melzack,
1992). The present study also demonstrated that the F1
fraction showed greater efficacy than the crude extract and
F2 fraction.
Phytochemical analysis indicates the presence of a
proanthocyanidin polymer of molecular weight 2114 Da in
the aqueous fraction (F1) (Ishida et al., 2006) and
condensed tannins (flavan-3-ols and prodelphinidins and
prorobinetinidins) in F2 (De Mello et al., 1996a, b, 1999).
From the data of this study we can conclude that the
barbatimão extract has a peripheral antinociceptive effect.
The mechanisms responsible for this effect are not
completely understood, but it is possible that the substances
responsible for the observed effect are concentrated in the
F1 fraction.
RESUMO
Efeito da casca de Stryphnodendron adstringens
(barbatimão) em modelos de nocicepção animais
A atividade antinociceptiva do extrato bruto e frações do
Stryphnodendron adstringens (Mart.) Coville (barbatimão)
foi avaliada. Foram usados três modelos experimentais
TABLE I - Analgesic activity of barbatimão extracts on nociception in the writhing, formalin, and hot plate tests.
Treatment Acetic acid Formalin test Hot plate test
(mg/kg body weight) Number of writhings Early phase Late phase 30 min 60 min
Saline 68.4 ± 3.3* 51.9 ± 3.9 239.2 ± 20.0 7.2 ± 0.8 8.3 ± 0.8
barbatimão 200 54.0 ± 7.0* - - - -
crude extracts 400 51.1 ± 3.6* - - - -
800 24.9 ± 7.2* 49.6 ± 3.1 130.5 ± 7.7* 8.2 ± 2.2 12.6 ± 1.3*
F1 200 45.2 ± 6.6* - - - -
400 30.2 ± 3.8* - - - -
800 23.3 ± 4.3* 46.7 ± 7.0 162.8 ± 7.3* 10.8 ± 1.6* 12.5 ± 1.3*
F2 200 74.5 ± 5.2* - - - -
400 52.1 ± 6.2* - - - -
800 32.8 ± 5.3* 53.1 ± 7.5 264.6 ± 13.7 9.6 ± 0.9 7.4 ± 0.6
Indomethacin 5 23.1 ± 5.3* 39.0 ± 9.0 44.8 ± 11.8* - -
Meperidine 50 - - - 28.6 ± 0.9* 24.8 ± 1.9*
F1 = aqueous fraction; F2 = ethyl-acetate fraction. Values are the mean ± S.E.M for 6-10 animals. Significant differences
compared to controls (saline) were evaluated using ANOVA (Tukey-test) *P < 0.05.
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para avaliação da dor: teste de contorção abdominal
induzida pelo ácido acético, teste da formalina e teste da
placa quente. Os resultados mostraram um efeito
antinociceptivo evidente do barbatimão nos modelos ex-
perimentais de contorção induzida por ácido acético e dor
induzida pela formalina. Por outro lado, o barbatimão
não modificou significativamente o tempo de latência dos
animais no teste da placa quente. Estes resultados suge-
rem que o extrato de barbatimão apresenta efeito antino-
ciceptivo por mecanismos periféricos.
UNITERMOS: Stryphnodendron adstringens. Barbatimão.
Antinocicepção.
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